Skip to main content
. Author manuscript; available in PMC: 2014 Apr 3.
Published in final edited form as: Am J Nephrol. 2013 Apr 3;37(5):10.1159/000349930. doi: 10.1159/000349930

Table 3. Clinical outcomes.

Metabolic syndrome p

Yes (34) No (40)
CVE, n (%) 0.24
 MI 2 (5.9) 0 (0.0)
 Angina 2 (5.9) 1 (2.5)
 CHF 1 (2.9) 1 (2.5)
NODAT, n (%) 8 (25.3) 2 (5.0) 0.04
Acute rejection, n (%) 12 (35.3) 8 (20.0) 0.14
Graft loss, n (%) 6 (17.6) 2 (5.0) 0.08
Patients with any event*, n (%) 21 (61.8) 11 (27.5) 0.003
eGFR, ml/min (SD) 53.9 (21.2) 57.1 (18.7) 0.52
*

Some patients had more than one event.